Bank of America Corp DE lessened its holdings in Maximus, Inc. (NYSE:MMS – Free Report) by 72.0% during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 250,493 shares of the health services provider’s stock after selling 644,354 shares during the period. Bank of America Corp DE owned approximately 0.44% of Maximus worth $18,699,000 at the end of the most recent reporting period.
Other institutional investors also recently modified their holdings of the company. Barclays PLC raised its position in Maximus by 285.1% in the third quarter. Barclays PLC now owns 170,971 shares of the health services provider’s stock worth $15,927,000 after acquiring an additional 126,573 shares during the period. UMB Bank n.a. increased its stake in shares of Maximus by 79.8% during the 4th quarter. UMB Bank n.a. now owns 356 shares of the health services provider’s stock worth $27,000 after purchasing an additional 158 shares during the last quarter. Fort Washington Investment Advisors Inc. OH raised its holdings in shares of Maximus by 39.1% in the 4th quarter. Fort Washington Investment Advisors Inc. OH now owns 296,476 shares of the health services provider’s stock worth $22,132,000 after purchasing an additional 83,390 shares during the period. Janney Montgomery Scott LLC lifted its stake in Maximus by 79.7% in the fourth quarter. Janney Montgomery Scott LLC now owns 5,949 shares of the health services provider’s stock valued at $444,000 after purchasing an additional 2,638 shares during the last quarter. Finally, Inspire Investing LLC grew its holdings in Maximus by 20.9% during the fourth quarter. Inspire Investing LLC now owns 5,374 shares of the health services provider’s stock valued at $401,000 after purchasing an additional 929 shares during the period. 97.21% of the stock is owned by institutional investors.
Maximus Trading Down 0.5%
NYSE:MMS opened at $74.80 on Wednesday. The company has a market cap of $4.21 billion, a P/E ratio of 16.09 and a beta of 0.61. Maximus, Inc. has a 1 year low of $63.77 and a 1 year high of $93.97. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.72 and a quick ratio of 1.72. The stock’s fifty day moving average price is $69.04 and its two-hundred day moving average price is $72.49.
Maximus Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Saturday, May 31st. Stockholders of record on Thursday, May 15th will be given a $0.30 dividend. The ex-dividend date is Thursday, May 15th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.60%. Maximus’s dividend payout ratio (DPR) is currently 23.86%.
Analysts Set New Price Targets
Separately, StockNews.com lowered Maximus from a “buy” rating to a “hold” rating in a research note on Thursday, May 15th.
View Our Latest Stock Report on MMS
Insider Activity at Maximus
In other news, Director Jan Madsen sold 2,439 shares of the firm’s stock in a transaction on Tuesday, March 18th. The shares were sold at an average price of $67.71, for a total transaction of $165,144.69. Following the sale, the director now owns 18,097 shares in the company, valued at approximately $1,225,347.87. This trade represents a 11.88% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. 1.60% of the stock is owned by corporate insiders.
Maximus Company Profile
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Read More
- Five stocks we like better than Maximus
- What Are Earnings Reports?
- Top 5 Stocks Hedge Funds Are Buying Right Now
- What is the FTSE 100 index?
- Viking Holdings Posts Strong Q1, Eyes Growth Ahead
- The Role Economic Reports Play in a Successful Investment Strategy
- 2 Reasons Netflix’s 40% Rally Is Far From Over
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.